VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
463
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
93
Interactions with Platform & by Email
PARTICIPANTS
19
Unique # Participated
VALIDATIONS
9
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
210
PAGES
261
EDITION
16
PRICE
USD $5600
Is the U.S. Still a Better Global Barometer than China?
Amid the COVID-19 crisis, the global market for Intravenous (IV) Iron Drugs estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.6 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Ferric Carboxyl Maltose, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Iron Sucrose segment is readjusted to a revised 5.4% CAGR for the next 7-year period.
The Intravenous (IV) Iron Drugs market in the U.S. is estimated at US$458.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$554.7 Million by the year 2027 trailing a CAGR of 9.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
In the global Other Product Types segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$338.9 Million in the year 2020 will reach a projected size of US$445.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$344.5 Million by the year 2027, while Latin America will expand at a 5.4% CAGR through the analysis period. We bring years of research experience to this 16th edition of our report. The 261-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Allergan Plc.; AMAG Pharmaceuticals Inc.; American Regent Inc.; Luitpold Pharmaceuticals; Pharmacosmos A/S; Sanofi US; Vifor Fresenius Medical Care Renal Pharma; Vifor Pharma Ltd.
» Product Type (Ferric Carboxyl Maltose, Iron Sucrose, Other Product Types) » Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Other Applications)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlassâ„¢ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Iron Deficiency Anemia (IDA) - An Overview |
| Recent Market Activity |
| Intravenous (IV) Iron Drugs Market - A Quick Primer |
| US and Europe Dominate IV Iron Market |
| Asia-Pacific - The Fastest Growing Market |
| Leading Intravenous Iron Drugs Globally |
| Leading IV Iron Drugs Available in the Market |
| Leading Intravenous Iron Drugs: In a Nutshell |
| Ferinject/Injectafer - The Leading Intravenous Iron Drug Globally |
| Venofer® - Looses Ground to Ferinject |
| Feraheme Obtains Broader Label Approval |
| Feraheme® Obtains FDA Filing Acceptance for Treating All Adult Patients Suffering from IDA |
| Gluconate (Ferrlecit® and Nulecit) |
| Dextran |
| Global Market Leaders |
| Global Competitor Market Shares |
| Intravenous (IV) Iron Drugs Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Allergan Plc. (Ireland) |
| AMAG Pharmaceuticals, Inc. (USA) |
| Daiichi Sankyo, Inc. (USA) |
| Luitpold Pharmaceuticals, Inc. (USA) |
| American Regent, Inc. (USA) |
| Pharmacosmos A/S (Denmark) |
| Sanofi US (USA) |
| Vifor Pharma Ltd. (Switzerland) |
| Vifor Fresenius Medical Care Renal Pharma (Switzerland) |
| 3. MARKET TRENDS & DRIVERS |
| Expanding Pool of ESRD and CKD Patients - The Major Growth Driver for Intravenous (IV) Iron Drugs |
| ESRD Prevalence Statistics: An Opportunity Indicator |
| Increase in Healthcare Spending Bodes Well for Intravenous Iron Drugs Market |
| Dialysis Patients - A Major Market for Intravenous Iron Supplements |
| Ageing Population Drives Demand for IV Iron Drugs |
| Shifting Preference from Oral Iron Drugs to Intravenous Iron Drugs |
| Comparison of Ferrous Salts with IV Iron Therapy |
| Other Chronic Diseases with IDA Offer Prospects for IV Iron Drugs |
| Anemia in Heart Failure - A Market with Huge Potential |
| Chemotherapy Induced Anemia to Promote IV Iron Supplements |
| Correction of IDA in Pregnancy Signals Opportunities |
| Women’s Health - A Key Growth Opportunity |
| Perioperative and Postoperative Anemia - A Niche Market Beckons |
| Adverse Reactions of IV Iron Preparations Raise Concerns |
| Dosing Limitations Plague IV Iron Market |
| 4. GLOBAL MARKET PERSPECTIVE |
| Intravenous (IV) Iron Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Intravenous (IV) Iron Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Ferric Carboxyl Maltose (Product Type) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Ferric Carboxyl Maltose (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Ferric Carboxyl Maltose (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Iron Sucrose (Product Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Iron Sucrose (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Iron Sucrose (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Other Product Types (Product Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Other Product Types (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Other Product Types (Product Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Chronic Kidney Disease (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Chronic Kidney Disease (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Chronic Kidney Disease (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Inflammatory Bowel Disease (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025 |
| Inflammatory Bowel Disease (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017 |
| Inflammatory Bowel Disease (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Cancer (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025 |
| Cancer (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017 |
| Cancer (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Intravenous (IV) Iron Drugs Market Share (in %) by Company: 2020 & 2025 |
| United States Intravenous (IV) Iron Drugs Market Estimates and Projections in US$ Million by Product Type: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market in the United States by Product Type: A Historic Review in US$ Million for 2009-2017 |
| United States Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| United States Intravenous (IV) Iron Drugs Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025 |
| Canadian Intravenous (IV) Iron Drugs Historic Market Review by Product Type in US$ Million: 2009-2017 |
| Intravenous (IV) Iron Drugs Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2009, 2019, and 2025 |
| Canadian Intravenous (IV) Iron Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Canadian Intravenous (IV) Iron Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Japan |
| Japanese Market for Intravenous (IV) Iron Drugs: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2009-2017 |
| Japanese Intravenous (IV) Iron Drugs Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Intravenous (IV) Iron Drugs in US$ Million by Application: 2018 to 2025 |
| Japanese Intravenous (IV) Iron Drugs Market in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| China |
| Chinese Intravenous (IV) Iron Drugs Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025 |
| Intravenous (IV) Iron Drugs Historic Market Analysis in China in US$ Million by Product Type: 2009-2017 |
| Chinese Intravenous (IV) Iron Drugs Market by Product Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Demand for Intravenous (IV) Iron Drugs in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market Review in China in US$ Million by Application: 2009-2017 |
| Chinese Intravenous (IV) Iron Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Europe |
| Market Facts & Figures |
| European Intravenous (IV) Iron Drugs Market: Competitor Market Share Scenario (in %) for 2020 & 2025 |
| European Intravenous (IV) Iron Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Intravenous (IV) Iron Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2009-2017 |
| European Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| European Intravenous (IV) Iron Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| European Intravenous (IV) Iron Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| France |
| Intravenous (IV) Iron Drugs Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Intravenous (IV) Iron Drugs Historic Market Scenario in US$ Million by Product Type: 2009-2017 |
| French Intravenous (IV) Iron Drugs Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 |
| French Intravenous (IV) Iron Drugs Historic Market Review in US$ Million by Application: 2009-2017 |
| French Intravenous (IV) Iron Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Germany |
| Intravenous (IV) Iron Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025 |
| German Intravenous (IV) Iron Drugs Historic Market Analysis in US$ Million by Product Type: 2009-2017 |
| German Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| German Intravenous (IV) Iron Drugs Market in Retrospect in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Intravenous (IV) Iron Drugs Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025 |
| Intravenous (IV) Iron Drugs Historic Market Analysis in Italy in US$ Million by Product Type: 2009-2017 |
| Italian Intravenous (IV) Iron Drugs Market by Product Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Demand for Intravenous (IV) Iron Drugs in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market Review in Italy in US$ Million by Application: 2009-2017 |
| Italian Intravenous (IV) Iron Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| United Kingdom |
| United Kingdom Market for Intravenous (IV) Iron Drugs: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025 |
| Intravenous (IV) Iron Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2009-2017 |
| United Kingdom Intravenous (IV) Iron Drugs Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Intravenous (IV) Iron Drugs in US$ Million by Application: 2018 to 2025 |
| United Kingdom Intravenous (IV) Iron Drugs Market in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| Spain |
| Spanish Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025 |
| Spanish Intravenous (IV) Iron Drugs Historic Market Review by Product Type in US$ Million: 2009-2017 |
| Intravenous (IV) Iron Drugs Market in Spain: Percentage Share Breakdown of Sales by Product Type for 2009, 2019, and 2025 |
| Spanish Intravenous (IV) Iron Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Spanish Intravenous (IV) Iron Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Russia |
| Russian Intravenous (IV) Iron Drugs Market Estimates and Projections in US$ Million by Product Type: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market in Russia by Product Type: A Historic Review in US$ Million for 2009-2017 |
| Russian Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Russian Intravenous (IV) Iron Drugs Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Historic Demand Patterns in Russia by Application in US$ Million for 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2009-2017 |
| Rest of Europe Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Rest of Europe Intravenous (IV) Iron Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Rest of Europe Intravenous (IV) Iron Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Asia-Pacific Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
| Asia-Pacific Intravenous (IV) Iron Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Intravenous (IV) Iron Drugs Historic Market Scenario in US$ Million by Product Type: 2009-2017 |
| Asia-Pacific Intravenous (IV) Iron Drugs Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 |
| Asia-Pacific Intravenous (IV) Iron Drugs Historic Market Review in US$ Million by Application: 2009-2017 |
| Asia-Pacific Intravenous (IV) Iron Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Australia |
| Intravenous (IV) Iron Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025 |
| Australian Intravenous (IV) Iron Drugs Historic Market Analysis in US$ Million by Product Type: 2009-2017 |
| Australian Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Australian Intravenous (IV) Iron Drugs Market in Retrospect in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025 |
| India |
| Indian Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025 |
| Indian Intravenous (IV) Iron Drugs Historic Market Review by Product Type in US$ Million: 2009-2017 |
| Intravenous (IV) Iron Drugs Market in India: Percentage Share Breakdown of Sales by Product Type for 2009, 2019, and 2025 |
| Indian Intravenous (IV) Iron Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Indian Intravenous (IV) Iron Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| South Korea |
| Intravenous (IV) Iron Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025 |
| South Korean Intravenous (IV) Iron Drugs Historic Market Analysis in US$ Million by Product Type: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Distribution in South Korea by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025 |
| South Korean Intravenous (IV) Iron Drugs Historic Market Analysis in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific |
| Rest of Asia-Pacific Market for Intravenous (IV) Iron Drugs: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product Type for the Period 2009-2017 |
| Rest of Asia-Pacific Intravenous (IV) Iron Drugs Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Demand Estimates and Forecasts for Intravenous (IV) Iron Drugs in US$ Million by Application: 2018 to 2025 |
| Rest of Asia-Pacific Intravenous (IV) Iron Drugs Market in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025 |
| Latin America |
| Latin American Intravenous (IV) Iron Drugs Market Trends by Region/Country in US$ Million: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Intravenous (IV) Iron Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Latin American Intravenous (IV) Iron Drugs Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025 |
| Intravenous (IV) Iron Drugs Historic Market Analysis in Latin America in US$ Million by Product Type: 2009-2017 |
| Latin American Intravenous (IV) Iron Drugs Market by Product Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Latin American Demand for Intravenous (IV) Iron Drugs in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market Review in Latin America in US$ Million by Application: 2009-2017 |
| Latin American Intravenous (IV) Iron Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Argentina |
| Argentinean Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Argentina in US$ Million by Product Type: A Historic Review for the Period 2009-2017 |
| Argentinean Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Argentinean Intravenous (IV) Iron Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Argentinean Intravenous (IV) Iron Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Brazil |
| Intravenous (IV) Iron Drugs Market in Brazil by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Brazilian Intravenous (IV) Iron Drugs Historic Market Scenario in US$ Million by Product Type: 2009-2017 |
| Brazilian Intravenous (IV) Iron Drugs Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Quantitative Demand Analysis in Brazil in US$ Million by Application: 2018-2025 |
| Brazilian Intravenous (IV) Iron Drugs Historic Market Review in US$ Million by Application: 2009-2017 |
| Brazilian Intravenous (IV) Iron Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Mexico |
| Intravenous (IV) Iron Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025 |
| Mexican Intravenous (IV) Iron Drugs Historic Market Analysis in US$ Million by Product Type: 2009-2017 |
| Mexican Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Mexican Intravenous (IV) Iron Drugs Market in Retrospect in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025 |
| Rest of Latin America |
| Rest of Latin America Intravenous (IV) Iron Drugs Market Estimates and Projections in US$ Million by Product Type: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market in Rest of Latin America by Product Type: A Historic Review in US$ Million for 2009-2017 |
| Rest of Latin America Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Rest of Latin America Intravenous (IV) Iron Drugs Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025 |
| Middle East |
| The Middle East Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
| The Middle East Intravenous (IV) Iron Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025 |
| The Middle East Intravenous (IV) Iron Drugs Historic Market by Product Type in US$ Million: 2009-2017 |
| Intravenous (IV) Iron Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Product Type for 2009, 2019, and 2025 |
| The Middle East Intravenous (IV) Iron Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| The Middle East Intravenous (IV) Iron Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Iran |
| Iranian Market for Intravenous (IV) Iron Drugs: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Iran: Historic Sales Analysis in US$ Million by Product Type for the Period 2009-2017 |
| Iranian Intravenous (IV) Iron Drugs Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| Iranian Demand Estimates and Forecasts for Intravenous (IV) Iron Drugs in US$ Million by Application: 2018 to 2025 |
| Iranian Intravenous (IV) Iron Drugs Market in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025 |
| Israel |
| Israeli Intravenous (IV) Iron Drugs Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Israel in US$ Million by Product Type: A Historic Review for the Period 2009-2017 |
| Israeli Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Israeli Intravenous (IV) Iron Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Intravenous (IV) Iron Drugs Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Israeli Intravenous (IV) Iron Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Saudi Arabia |
| Saudi Arabian Intravenous (IV) Iron Drugs Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025 |
| Intravenous (IV) Iron Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Product Type: 2009-2017 |
| Saudi Arabian Intravenous (IV) Iron Drugs Market by Product Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Saudi Arabian Demand for Intravenous (IV) Iron Drugs in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market Review in Saudi Arabia in US$ Million by Application: 2009-2017 |
| Saudi Arabian Intravenous (IV) Iron Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| United Arab Emirates |
| Intravenous (IV) Iron Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025 |
| United Arab Emirates Intravenous (IV) Iron Drugs Historic Market Analysis in US$ Million by Product Type: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Distribution in United Arab Emirates by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025 |
| United Arab Emirates Intravenous (IV) Iron Drugs Historic Market Analysis in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025 |
| Rest of Middle East |
| Intravenous (IV) Iron Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025 |
| Rest of Middle East Intravenous (IV) Iron Drugs Historic Market Analysis in US$ Million by Product Type: 2009-2017 |
| Rest of Middle East Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| Intravenous (IV) Iron Drugs Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Rest of Middle East Intravenous (IV) Iron Drugs Market in Retrospect in US$ Million by Application: 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025 |
| Africa |
| African Intravenous (IV) Iron Drugs Market Estimates and Projections in US$ Million by Product Type: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Market in Africa by Product Type: A Historic Review in US$ Million for 2009-2017 |
| African Intravenous (IV) Iron Drugs Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| African Intravenous (IV) Iron Drugs Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Intravenous (IV) Iron Drugs Historic Demand Patterns in Africa by Application in US$ Million for 2009-2017 |
| Intravenous (IV) Iron Drugs Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 20 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com